Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Stromal MED12 exon 2 mutations in complex fibroadenomas of the breast

Journal of Clinical Pathology(2020)10.1136/jclinpath-2020-207062Source: DataRank Database

Stromal MED12 exon 2 mutations in complex fibroadenomas of the breast is a research paper published in Journal of Clinical Pathology (2020). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.40)OA: hybridTopics (75)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Francisco Beça ORCID,Ana Paula Martins Sebastião ORCID,Melissa P. Murray ORCID,Catarina Silveira ORCID,Arnaud Da Cruz Paula ORCID

Live enrichment

PubMed:33376197 PMC:PMC8260148 OpenAlex:https://openalex.org/W3116588880

K12

Grant: CA184746

Fundação para a Ciência e Tecnologia

Grant: SFRH/BDE/110544/2015

Cancer Center Support Grant of the National Institutes of Health/National Cancer Institute

Grant: P30CA008748

NCI NIH HHS

Grant: K12 CA184746

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

Grant: 5K12CA184746-02

MSK Paul Calabresi Career Development Award for Clinical Oncology

Cycle for survival

Breast Cancer Research Foundation

FWCI

0.40

Citation Percentile

0.6%

Citation Trend

2022

2025

hybridLicense: cc-by-nc

journalhttps://jcp.bmj.com/content/jclinpath/75/2/133.full.pdf

publisherhttps://jcp.bmj.com/content/jclinpath/75/2/133.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/jclinpath-2020-207062

journalhttps://doi.org/10.1136/jclinpath-2020-207062

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33376197

Fields of Study

Breast Lesions and CarcinomasCancer and Skin LesionsBreast Cancer Treatment Studies03 medical and health sciences0302 clinical medicineAdultAgedAged, 80 and overBiomarkers, TumorBiopsyBreast NeoplasmsClass I Phosphatidylinositol 3-KinasesDNA Mutational AnalysisExonsFemaleFibroadenomaGenetic Predisposition to DiseaseHumansMediator ComplexMiddle AgedMutationPhenotypeStromal CellsTelomerase

MeSH Terms

AdultAgedAged, 80 and overBiopsyBreast NeoplasmsDNA Mutational AnalysisExonsFemaleHumansMiddle AgedMutationPhenotypeBiomarkers, TumorStromal CellsFibroadenomaTelomeraseGenetic Predisposition to DiseaseMediator ComplexClass I Phosphatidylinositol 3-Kinases

Keywords

ExonSanger sequencingBiologyGeneticsLaser capture microdissectionMolecular biologyStromal cellGeneMutationCancer researchBreastPathologyMolecularBreast neoplasmsAdultClass I Phosphatidylinositol 3-KinasesBiopsyDNA Mutational AnalysisShort ReportBiomarkers, TumorHumansGenetic Predisposition to DiseaseTelomeraseAgedAged, 80 and overMediator ComplexExonsMiddle AgedPhenotypeFibroadenomaFemaleStromal Cells

Sustainable Development Goals

SDG 3: 3. Good health